European Comimssion approves Afqlir, a biosimilar to reference medicine Eylea for various retinal diseases – Sandoz
Sandoz, announced that the European Commission (EC) has granted marketing authorization for Afqlir (aflibercept) 2 mg vial kit and pre-filled syringe for intravitreal injection, a biosimilar to reference… read more.
